SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sensorion to Present Gene Therapy Research at ESGCT Congress

Sensorion will present gene therapy research at the ESGCT Annual Congress.

SquawkNews Desk 1 updates Updated Oct 28, 2026, 06:36 AM UTC

Story updates

06:36:18 AM UTC
SquawkNews
Sensorion to Present SENS-601 Gene Therapy Research for Genetic Hearing Loss at ESGCT Congress S

Related stories

Upbound Group Expects Q4 Revenue of $1.15B-$1.25B M impact | EQUITY | Oct 29, 2026, 11:17 AM UTC Kymera Reports Q3 2026 Results, $132 Million Net Loss and $1.6 Billion in Cash Kymera reported a third-quarter 2026 net loss of $132.0 million, up from $82.2 million a year earlier. It ended September with $1.6 billion in cash, cash equivalents and investment M impact | EQUITY | Oct 29, 2026, 11:17 AM UTC Transuite.org Signs LOI to Acquire 51% of Zhongke Haichuang Transuite.org signed a letter of intent to acquire 51% of Zhongke Haichuang by end-2026. Subsidiary SolanAI has non-binding 2026 internal targets of about $60 million in revenue an M impact | EQUITY | Oct 29, 2026, 11:17 AM UTC Altria Reports Higher Third-Quarter 2026 Net Profit and Revenue Altria reported higher net profit and net revenue in the third quarter of 2026 compared with the prior-year quarter. M impact | EQUITY | Oct 29, 2026, 11:16 AM UTC Insmed shares jump 20.1% premarket after Q3 revenue beat M impact | EQUITY | Oct 29, 2026, 11:16 AM UTC eBay Climbs After Upbeat Annual Forecast, Earnings Beat eBay shares climbed after the company issued an upbeat annual forecast and reported an earnings beat. M impact | EQUITY | Oct 29, 2026, 11:16 AM UTC